ERBB2 and breast cancer: HER2 is an important signaling pathway in tumor growth and involved in regulating autophagy, blockage of HER2/Beclin1 binding increases autophagy, with a previous study finding that HER2 interacts with Beclin1 in breast cancer cells and inhibits autophagy [36].